Author

Esraa Salim

North Carolina Central University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

John E. Scott· 1 shared Kevin P. WilliamsiD· 1 shared Maria S. DixoniD· 1 shared Michael TarpleyiD· 1 shared Weifan ZhengiD· 1 shared Xiaojia Ji· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

John E. Scott

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells

Esraa Salim, Xiaojia Ji, Michael Tarpley, Maria S. Dixon, Weifan Zheng, John E. Scott, Kevin P. Williams

This study validates computational drug repurposing predictions for inflammatory breast cancer using experimental assays, identifying synergistic combinations that inhibit cancer cell growth and signaling pathways.

PLoS ONE · Sep 16, 2026Peer-reviewedCancer Biology